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Abstract
Background: Constitutive promoters that ensure sustained and high level gene expression are basic research tools that
have a wide range of applications, including studies of human embryology and drug discovery in human embryonic stem
cells (hESCs). Numerous cellular/viral promoters that ensure sustained gene expression in various cell types have been
identified but systematic comparison of their activities in hESCs is still lacking.
Methodology/Principal Findings: We have quantitatively compared promoter activities of five commonly used constitutive
promoters, including the human b-actin promoter (ACTB), cytomegalovirus (CMV), elongation factor-1a,( E F 1 a),
phosphoglycerate kinase (PGK) and ubiquitinC (UbC) in hESCs. Lentiviral gene transfer was used to ensure stable
integration of promoter-eGFP constructs into the hESCs genome. Promoter activities were quantitatively compared in long
term culture of undifferentiated hESCs and in their differentiated progenies.
Conclusion/Significance: The ACTB, EF1a and PGK promoters showed stable activities during long term culture of
undifferentiated hESCs. The ACTB promoter was superior by maintaining expression in 75–80% of the cells after 50 days in
culture. During embryoid body (EB) differentiation, promoter activities of all five promoters decreased. Although the EF1a
promoter was downregulated in approximately 50% of the cells, it was the most stable promoter during differentiation.
Gene expression analysis of differentiated eGFP+ and eGFP- cells indicate that promoter activities might be restricted to
specific cell lineages, suggesting the need to carefully select optimal promoters for constitutive gene expression in
differentiated hESCs.
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Introduction
Human embryonic stem cells (hESCs) are derived from the
inner cell mass (ICM) of the blastocyst and have the unique
potential to differentiate to any cell type of fetal and adult tissues
[1]. In this sense, hESCs offers an expandable source of in vitro
derived human cells that can be used for a wide diversity of
applications such as regenerative medicine and cell replacement
therapies. However, to fully explore the potential of hESCs, it is
important to understand the basic processes that control growth
and differentiation of hESCs.
To reveal the molecular pathways behind growth and
differentiation of hESCs, efficient genetic engineering techniques
are advantageous tools for controlled expression of key regulatory
genes or to introduce fluorescent reporter genes such as enhanced
green fluorescent protein (eGFP). In these processes, constitutive
promoters are useful tools due to their high level of expression in
most cell types. The constitutive cytomegalovirus (CMV) enhanc-
er/chicken b-actin promoter (CAG) promoter was recently used
for generation of endodermal progenitor cells from hESCs by
overexpression of SOX17 and SOX7 [2]. To reprogram somatic
cells into induced pluripotent cells (iPSCs), the constitutively active
elongation factor-1a (EF1a) promoter was used to overexpress the
four transcription factors SOX2, OCT3/4, KLF4 and c-MYC [3–5].
Moreover, to monitor and track iPSCs generated from mouse
embryonic fibroblasts the EF1a promoter was used to constitu-
tively express eGFP [4]. Thereby, continously expressed fluores-
cent reporter/marker genes holds an emerging promise as tools for
live imaging of hESCs in vitro and also for identification of
differentiating hESCs in animal grafting experiments without
using time consuming species-specific antibody labeling systems or
in situ hybridization.
Different eukaryotic/mammalian and viral promoters have
been reported to efficiently drive expression of transgenes in
hESCs. The Envy hESC line expresses eGFP both in undifferen-
tiated cells and in their differentiated progenies as a result of stable
integration of a human b-actin promoter(ACTB)-driven eGFP
gene [6]. The CMV promoter has been reported to mediate strong
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human ESCs remains controversial [7–9]. The phosphoglycerate
kinase (PGK) and the EF1a promoters have also been effectively
used for long term constitutive transgene expression in ESCs.
Whereas the EF1a- and PGK promoters were shown to mediate
stable long term expression of eGFP in hESCs, the CMV
promoter only mediated transient expression [10]. Consistently,
in mouse ES cells (mESCs), the EF1a and PGK promoters are
more stable than the CMV promoter [8]. Additional comparative
studies of the CMV and EF1a promoters showed that EF1a is
superior to the CMV promoter in undifferentiated mouse, monkey
and human ESCs [11]. The EF1a promoter was used to generate
stable EF1a-eGFP hESCs that maintained eGFP expression up to
four weeks of culture. Furthermore, the mammalian ubiquitinC
(UbC) promoter was found to stably drive eGFP expression in
hESCs, but at moderate levels compared to the more commonly
used CAG promoter [9].
Thus, diverse constitutive promoters have been tested in mouse
and human ESCs, but a comprehensive comparison of constitutive
promoter activity and stability in undifferentiated and differenti-
ated hESCs is still lacking. For this purpose, we performed a
comparative study of the activities of the ACTB, CMV, EF1a,
PGK and UbC promoters in hESCs. Lentiviral mediated gene
transfer was chosen as gene delivery system since it is known to
efficiently introduce genetic material into the hESC genome
[12,13]. In addition, compared to traditional retroviral vectors,
lentiviral gene expression is maintained during propagation and
differentiation of embryonic stem cells [14]. Other viral systems,
such as adenovirus have been used for gene delivery into hESCs
but since they usually do not integrate their genome into the host
chromosomes, transgenes can only be transiently expressed
[15,16]. The constitutive promoters were cloned into lentiviral
self-inactivating vectors that lack endogenous promoter activity
from the long terminal repeats. Transcription of an eGFP gene
present in the lentiviral vectors was therefore solely driven by the
introduced constitutive promoters. Promoter activity was moni-
tored by the expression of eGFP in long term culture of
undifferentiated hESCs and in cells differentiated into all three
embryonic germ layers. Our data demonstrate that ACTB and
PGK promoters mediated stable transcriptional activity resulting
in high levels of transgene expression in long term culture of
undifferentiated hESCs. Transcriptional activities of all five
promoters were downregulated during differentiation of hESCs.
Notably, despite this downregulation, some promoters sustained
reporter gene expression in a germ layer-specific manner.
Results
Lentiviral transduction and gene copy number
determination
The hESC line SA121 was transduced with ACTB-, CMV-,
EF1a-, PGK- and UbC-eGFP self-inactivating lentiviral vectors
(Fig. 1A). Efficiency of transductions was measured by flow
cytometry (FACS) as percentage eGFP+ cells. To be able to
quantitatively compare eGFP expression between the different
promoters we aimed for similar copy numbers of integrated
viral vectors. In addition, to avoid insertional mutagenesis, we
transduced hESCs with low vector to target cell ratios. Initial test
transduction experiments revealed that multiplicity of infection
(MOI) 1 would generate transduction efficiencies up to 35%
eGFP+cells for hESC line SA121 for the CMV-, EF1a and PGK-
eGFP lentiviral vectors (Fig. S1A). Based on these experiments,
Figure 1. Transduction efficiency in hESCs SA121. A. Schematic representation of pTRIP lentiviral vectors, in which eGFP are under the control
of ACTB-, CMV-, EF1a-, PGK- or UbC promoters. The hESC line SA121 was transduced with lentiviral vectors; pTRIP-ACTB-, CMV-, EF1a-, PGK-or UbC-
eGFP. Ten days after transduction, cell populations were analyzed by FACS to determine the percentage of cells that expressed GFP. B. Percentage of
transduced hESCs expressing eGFP. C. Determination of number of transgenic inserts in the GFP positive cells by qPCR at time of FACS isolation (day
0) and after 50 days of culture. Data in A and B are shown as mean of three independent experiments. Error bars represent standard deviation of the
mean (6s.d.).
doi:10.1371/journal.pone.0012413.g001
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CMV-, PGK and UbC-eGFP lentiviral vectors, which generated a
maximum of 20% eGFP+ cells (Fig. 1B). Previous reports have
showed that nonintegrated lentiviral vectors transiently expressed
the transgene up to 10 days after transduction and thereafter
gradually decreased as a result of dilution of the vector genome
through cell divisions. [17,18]. Therefore, transduction efficiencies
were analyzed 10 days after transduction in order to avoid
detection of transgene expression from nonintegrated vectors.
qPCR on genomic DNA from FACS-isolated eGFP+ cells
demonstrated that on average 1–2 viral vector copies per eGFP+
cell were integrated in ACTB-, CMV-, EF1a- and UbC-eGFP
cells (Fig. 1C). PGK-eGFP transduced cells contained approxi-
mately 5 vector copies per eGFP+ cell. After 50 days of culture of
eGFP+ isolated cells, copy numbers were detected at similar levels
as immediately after FACS isolation with the exception of UbC
promoters that decreased from average 2 vector copies to 1 copy
per eGFP+ cell (Fig. 1C). Average gene copy numbers were
measured by comparing the amount of eGFP and CDX2 amplified
PCR products. Generation of a standard curve verified linear
amplification of eGFP and CDX2 genomic DNA amplicons at
similar efficiency (Fig. S1F).
Promoter activity in undifferentiated hESCs
To be able to quantitatively compare the activity of the different
promoters, we isolated eGFP+ cells from the promoter-eGFP
transduced populations by FACS sorting. Results for promoter-
eGFP transduced populations are representative of three inde-
pendent transductions that were FACS sorted separately and
eGFP+ isolated cells were maintained as separate cell cultures in
order to exclude possible variation in transductions or mainte-
nance of cells. eGFP+ sorted cells exhibited characteristic hESC
morphology and uniform expression of pluripotency markers
OCT3/4, NANOG, and hES-Cellect (Cellartis AB) when cultured
on Matrigel in mTESR cell culture medium, confirming that the
transduction and FACS-sorting procedure did not affect hESC
pluripotency (Fig. 2C–L). Promoter activity was measured 15, 30
and 50 days after FACS sorting and the sorting day was referred to
as day 0. Percentage eGFP+ at day0 was approximately 98% for
all promoters since reanalysis of sorted cells showed a purity of 97–
100% eGFP+ cells (Fig. 2A and Table 1). The ACTB-, EF1a- and
PGK promoters were found to be more efficient than CMV in
driving long term expression of eGFP. In particular, the ACTB
and PGK promoters mediated sustained eGFP expression
(74,065,8% and 74,4610,6%) after 50 days in culture (Table 1).
Equal promoter activities were detected for ACTB, EF1a and
PGK up to day 30 but thereafter EF1a activity decreased. The
percentage of CMV-eGFP+ cells decreased to 6,762,9% at day
50. Already at day 7, the CMV promoter was rapidly
downregulated and was expressed in approximately 30% of the
cells (data not shown). Activity of the UbC promoter was observed
in 6264,5% of the total cell populations at day 15 and decreased
to 24,8610,4% after 50 days of culture (Fig. 2A and Table 1). At
day 50, promoter activities for ACTB, EF1a and PGK were
significantly higher than for the CMV promoter (p#0.0001
students t’test).
To evaluate the strength of each promoter during maintenance
of hESCs, the intensity of the eGFP fluorescent signal was
compared at day 0 and day 50 (Fig. 2B). All promoters mediated
eGFP expression with similar intensity on day0. After 50 days, the
ACTB and PGK promoters maintained high eGFP expression
levels, whereas expression levels dropped with CMV, EF1a and
UbC and promoters.
To verify that the measured promoter activities were not specific
to hESC line SA121, we repeated transduction experiments in
hESC line Hues-4 [19,20]. Transduction at MOI 1 resulted in low
copy number integration and transduction efficiencies below 40%
(Fig. S1A–C). The stability of the five constitutive promoters in
Hues-4 was similar to that measured in SA121 (Fig. S1D). Thus,
the ACTB-, EF1a- and PGK promoters maintained sustained
activity up to day 30 (86,560,1, 80,0610,1and 76,061,0%
eGFP+ cells) whereas CMV promoter activity deceased strongly
within 15 days (Table S1 and Fig. S1D). However, between day 30
and 50, the PGK promoter activity decreased more in Hues-4
than in SA121 (compare Fig. S1D with 2A). Like in SA121,
activities at day 50 were significantly higher for ACTB-, EF1a-
and PGK promoters than for CMV (p#0.001 students t’test). In
addition, intensity of the eGFP expression was comparable at day
0 for all promoters and showed similar pattern of stability as
measured in SA121 (Fig. S1E). These observations reveal that the
relative promoter stability and activity data are comparable
between the two tested cell lines.
In summary, of all the tested constitutive promoters the EF1a,
PGK and ACTB promoters were the most stable. The ACTB
promoter was the most superior promoter in undifferentiated
hESCs by maintaining transgene expression in 75–85% of the cells
after 50 days in culture in both cell lines tested. In addition, the
PGK promoter was found to express eGFP at high intensity up to
50 days of culture, whereas the intensities from the other
promoters decreased to various extents.
Promoter activity in differentiated hESCs
To test the effectiveness of the promoters in differentiated
hESCs, eGFP+ sorted cells were differentiated as embryoid bodies
for 22 days. Differentiation into cell lineages of all three embryonic
germ layers was verified by quantitative real time PCR (qPCR)
showing an increase of gene expression levels of endodermal,
mesodermal and ectodermal markers genes (Fig. 3A). In addition,
the expression level of the pluripotency marker OCT3/4
decreased. FACS analysis performed at the end of differentiation
demonstrated that promoter activities were less stable than in
undifferentiated hESCs (Fig. 3B). EF1a was the most stable
promoter during differentiation. Nevertheless, it was significantly
downregulated during differentiation and was inactive in approx-
imately 50% of the differentiated cells. In contrast to the stable
PGK activity detected in undifferentiated cells, its activity was
significantly downregulated during differentiation. The CMV
promoter was active in only a small portion of the cells
(approximately 15%) at start of the differentiation and was
therefore not included in differentiation studies.
To evaluate the strength of each promoter during EB
differentiation, intensity of eGFP fluorescent signal was measured
by FACS analysis of eGFP+ cells. During EB differentiation,
intensity of eGFP expression of ACTB- and EF1a was significantly
reduced, whereas eGFP fluorescent signal within the PGK- and
UbC-eGFP+ populations did not decrease during differentiation
(Fig. 3C).
The observation that promoter-mediated transgene expression
was downregulated during differentiation raised the question if
promoter activities could be restricted to specific cell lineages. To
address this, differentiated cells were separated into eGFP+ and
eGFP-populations by FACS sorting. Gene expression analysis of
eGFP+ and eGFP2 populations were carried out for quantifica-
tion of mRNA levels of marker genes representing the three
embryonic germ layers. Notably, in cells where the EF1a
promoter is active, mRNA expression levels of genes representing
all three embryonic germ layers were similar to or higher than the
Constitutive Promoters in hESC
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analysis showed that the EF1a promoter was less prone to
downregulation compared to other promoters during in vitro
differentiation (Fig. 3B).
SOX17, which is expressed in the primitive streak and
endoderm, is expressed at similar levels in EF1a -, PGK- and
UbC-eGFP+ cells compared to eGFP2 cells implying that these
promoters are active during mesendoderm differentiation (Fig. 4A).
In contrast, SOX17 expression was significantly reduced in ACTB-
eGFP+ cells compared to ACTB-eGFP2 cells. The hepatoblast
marker ALBUMIN was expressed at significantly lower levels in the
ACTB-, PGK- and UbC-eGFP+ populations compared to
GFP2cells, suggesting that these promoters are inactive in
hepatoblast cells (Fig. 4B).
Figure 2. Constitutive promoter activity in long term culture of undifferentiated hESCs. The hESC line SA121 was transduced with
lentiviral vectors containg the pTRIP-ACTB-, CMV-, EF1a-, PGK-or UbC-eGFP lentiviral vectors. 10 days after transduction, eGFP+ and eGFP2 cells were
separated by FACS sorting, referred to as day 0. Isolated eGFP+ cells were thereafter cultured for 50 days under self-renewing conditions and
promoter activities were measured by FACS analysis at day 0, 15, 30, and 50. A. Promoter activities as percentage of eGFP+ cells at day 0, 15, 30 and
50. B. Intensity of fluorescent signal of eGFP expression from the same eGFP positive cells that were FACS analysed day 0 and 50. Intensity was
measured by FACS analysis and EF1a promoter showed a significant decrease in intensity of eGFP expression from day 0 to day 50 (*p,0,014
students t’test). Decrease of ACTB-, CMV-, PGK- and UbC-eGFP intensity from day 0 to day 50 is not significant. A–C. Data are shown as mean of three
independent experiments. Error bars represent standard deviation of the mean (6 s.d.). C–L. Immunofluorescence stainings of ACTB-eGFP+ cells 30
days after FACS sorting. eGFP expressing cells show uniform expression of pluripotency markers; hES-Cellect (C), inset in C shows low and high
intensity eGFP expressing cells, Nanog (D–F) and Oct3/4 (G–I). L. Merged image of colony morphology of human ES cells cultured on Matrigel (K)
and eGFP expression within the colony (J). Scale bar in C represent 100 mM, inset and D–L 200 mM. Cells representative of high eGFP expressing is
indicated by arrowhead and low eGFP expression by arrow.
doi:10.1371/journal.pone.0012413.g002
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active, higher or equal mRNA levels for neural marker genes
PAX6 and NESTIN were detected compared to GFP2 cells,
indicating that all four promoters are active in neural progenitor
cells (Fig. 4C–D). PPARc is expressed in adipose tissues of
mesodermal origin. Both the EF1a- and the PGK promoter
exhibited similar mRNA expression levels of PPARc in eGFP+ vs
eGFP2 cells, suggesting that these promoters are active in the
PPARc+ cells (Fig. 4E). However, ACTB-eGFP+ cell populations
showed significantly lower levels of PPARc expression than GFP2
cells, indicating lower activity of ACTB promoter in PPARc+ cells.
Gene expression analysis of CD31, a marker for endothelial cells
was significantly lower in ACTB and PGK-eGFP+ populations,
suggesting that these promoters are inactive in endothelial cell
types (Fig. 4F). In contrast, EF1a-eGFP+ cells showed similar
levels of CD31 expression as EF1a -eGFP2 cells, suggesting that
the EF1a promoter efficiently drives eGFP expression in
endothelial cells (Fig. 4F).
Discussion
Promoter activity in undifferentiated hESCs
A number of different constitutive promoters have successfully
been reported to maintain stable transgene expression in hESCs
and are therefore good candidates in applications like cell lineage
tracing, generation of fluorescent reporter cell lines and overex-
pression of transcription factors. Much effort has focused on
techniques for stable integration of transgenes, but attempts to
quantitatively compare the effectiveness of constitutive promoters
to monitor and track cell fate determination in differentiating
hESCs are limited. Here, we quantitatively compare the efficiency
of ACTB, CMV, EF1a, PGK and UbC promoters to constitu-
tively drive eGFP expression both in undifferentiated cells and in
their differentiated progenies. To achieve this, we applied lentiviral
gene delivery to ensure high transduction efficiency and stable
transgene integration into the hESC genome. We reasoned that
the lentiviral system was more favorable for stable integration of
the transgene, than other approved transgene delivery methods in
hESCs such as transfection or adenoviral transduction, which are
more appropriate for transient expression [15,16,21,22]. More-
over, HIV-1-derived lentiviral vectors are efficient tools for stable
genetic modification of mammalian ES cells, since they are less
prone to silencing than traditional retroviral vectors [12,23–26].
Here, we provide relative data on promoter characteristics in
hESCs using eGFP as reporter gene and thus results presented
here are representative for constitutive promoter activities detected
as eGFP expression. Nevertheless, it cannot be excluded that
possible interference between the promoter and reporter gene
might influence transgene expression and therefore future studies
will have to resolve if different promoter/reporter combinations
will result in other expression and stability profiles than those
reported here.
The ACTB promoter was found to be the most stable promoter
mediating stable transgene (eGFP) expression during long term
culture (50 days) of undifferentiated hESCs. These observations
were observed in two independent hESC lines. This promoter has
previously been reported to stably express eGFP in both
undifferentiated cells and derivatives of all three embryonic germ
layers when inserted into to the Envy locus by transfection of
bacterial plasmids[6]. Here, we used lentivirus as gene delivery
tools for random insertion of the transgene and our data confirm
that the ACTB promoter has the potential to generate sustained
high level transgene expression in long term culture of undiffer-
entiated hESCs.
The percentage of eGFP+ cells in the EF1a transduced
populations decreased after 30 days in both hESC lines. Previous
publications suggest that the EF1a promoter acts as a strong and
stable promoter for transgene (eGFP) expression in hESCs [11–
13]. Thus, the EF1a promoter has been used to generate stable
eGFP expressing hESC lines with 95% of the cells maintaining
eGFP expression up to four weeks [11]. This is in line with our
data demonstrating stable eGFP expression up to 30 days in
culture. In another study, hESCs transduced with low viral vectors
copy numbers showed sustained high EF1a promoter activity for
up to 60 days in culture [13]. After 30 days the EF1a promoter
activity declined, albeit to a lower degree compared to in our
study. The observed difference in EF1a promoter activity during
long term culture of undifferentiated hESCs may be explained by
lentiviral vector design or differences related to hESC culture
techniques.
The percentage of eGFP+ cells in the PGK transduced
populations decreased after 30 days in one of the two hESC lines
studied. The PGK promoter has not been extensively studied in
hESCs and quantitative information about its activity in relation to
other constitutive promoters is lacking. Therefore, further studies
are needed to elucidate long term activity of the PGK promoter in
undifferentitated hESCs and possible variation of PGK promoter
activity between hESC lines.
In both cell lines, the UbC and CMV promoters experienced a
pronounced downregulation after 50 days in culture. This is
consistent with other reports demonstrating substantial loss of
UbC driven transgene expression in hESCs [9]. The rapid
downregulation of CMV promoter activity during long term
culture of undifferentiated hESCs is consistent with recent findings
demonstrating that the CMV promoter is not stably expressed in
undifferentiated mammalian ES cells [11,27]. Furthermore,
difficulties in obtaining stable CMV-eGFP expressing hESC lines
support the inability of the CMV promoter to sustain stable and
efficient transcriptional activity in undifferentiated hESCs [9,11].
Thus, of the analyzed promoters the UbC and CMV are the least
stable promoters during long term culture of undifferentiated
hESCs (Fig. 2A and S1).
In the present study, analysis of transgene expression is
performed on pools of transfected cells rather than isolated
subclones. Therefore, it could be hypothesized that loss of
transgene expression is caused by selective growth or survival of
subclones with low expression levels of the transgene. However, we
suggest that any negative effect of high transgene expression on
hESC growth and survival would manifest itself equally in all
promoter-eGFP transduced hESC cultures, rather than acting
only on certain promoter-eGFP transduced cultures but not on
others. Moreover, vector copy numbers remained constant
throughout the 50 days culture period for all promoters except
for the UbC promoter (Fig. 1C). Therefore, we propose that the
Table 1. % eGFP+ cells of hESC line SA121 transduced with
pTRIP-ACTB-, CMV-, EF1a-, PGK or UbC-eGFP lentiviral vectors.
Days ACTB CMV EF1a PGK UbC
0 9861 98,360,6 9861,5 97,760,6 98,360,6
15 80,566,1 27,967,1 79,964,8 80,6614,4 62,064,5
30 74,0610,5 7,160,7 69,364,2 75,063,8 43,6614,3
50 74,065,8 6,762,9 48,366,1 74,4610,6 24,9610,4
Data are shown as mean of three independent experiments 6 s.d.
doi:10.1371/journal.pone.0012413.t001
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PLoS ONE | www.plosone.org 5 August 2010 | Volume 5 | Issue 8 | e12413Figure 3. Promoter activity during differentiation of hESCs. A. Gene expression analysis of undifferentiated ACTB-, CMV-, EF1a-, PGK- or UbC-
eGFP transduced hESCs and after EB differentiation, plotted as relative to reference gene GAPDH. SOX17, ALBUMIN, PAX6, NESTIN, PPARc and, CD31
were used as marker genes for endodermal, ectodermal and mesodermal cell lineages and OCT3/4 as pluripotency marker. Results in A–C are plotted
as mean of three independent experiments and error bars indicate 6 s.d, B. hESC line SA121 was differentiated as embryonic bodies for 22 days and
promoter activities in ACTB-, CMV-, EF1a-, PGK- or UbC-eGFP transduced cells were measured by FACS analysis as % eGFP+ cells. In parallel, % eGFP+
cells were measured on ACTB-, CMV-, EF1a-, PGK- or UbC-eGFP transduced cells that were maintained in their undifferentiated state for 22 days.
Statistical analysis of EB day 22 as compared to undifferentiated day 22 (**p#0.0039 students t’test). C. Average level of intensity of eGFP fluorescent
signal of the eGFP+ population, detected by FACS analysis at start of differentiation, day 0 and after 22 days, measured as average mean fluorescence
intensity. Statistical analysis of EB d22 as compared to undifferentiated cells day 0 (**p,0.001,***p,0.0001 students t’test).
doi:10.1371/journal.pone.0012413.g003
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promoter-dependent variations in transgene expression rather
than variations in copy number and integration site in individual
cells.
To successfully use reporter cell lines to follow and track cells it
is important not only to ensure stable activity of the promoter but
also to rely on strong promoter activity. The latter is necessary to
ensure detectable levels of reporter gene expression. Thus, the
fluorescent signal detected from ACTB-, CMV-, EF1a-, PGK-
and UbC-eGFP expressing cells were used to assess strength of the
different promoters. At day 0, eGFP levels were expressed at
similar intensity for all five promoters. Notably, the ACTB and
PGK promoters expressed eGFP at stable intensity levels during
the 50-day observation period in both analyzed hESC lines (Fig. 2B
and S1E), suggesting that these promoters ensures stable levels of
transgene expression. In addition, the ACTB promoter stayed
active in the majority of transduced cells over time, indicating that
this is a strong and stable promoter in undifferentiated hESCs.
Promoter activity in differentiated hESCs
Ectopic expression of key regulatory genes is an important tool
to study mechanisms of differentiation and to induce cell fate
specification in hESCs. This emphasizes the need to identify
constitutive promoters that remains active at high and stable levels
not only in undifferentiated hESCs but also in their differentiated
progenies.
Figure 4. Activity of promoters in cell types representing all three embryonic germ layers. hESCs were spontaneously differentiated for
22 days and thereafter separated by FACS sorting into the eGFP+ and eGFP2 cell populations. Relative gene expression was performed by qPCR on
the eGFP+ and eGFP2 populations. A–F. Expression analysis of genes representative for differentiation to the three embryonic germ layers;
endoderm, mesoderm and ectoderm. SOX17(A) and ALBUMIN(B) originates from endoderm. Neural progenitors PAX6 (C) and NESTIN (D) originates
from ectoderm. E–F. Mesodermal cells; PPARc (E) and CD31 (F). Expression levels for each gene in eGFP+ and eGFP2 populations are plotted as
relative to expression levels in undifferentiated hESCs. Results are plotted as mean of three independent experiments and error bars indicate 6 s.d.
Statistical analysis of GFP+cells compared to GFP2 cells determined by students t’test (p*#0,0392).
doi:10.1371/journal.pone.0012413.g004
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activities of commonly used constitutive promoters decrease
during hESC differentiation to various extend, whereby the
EF1a promoter showed highest stability. Few attempts have been
made to quantify constitutive promoter activity during EB
differentiation of hESCs but it has been reported that in EF1a-
eGFP transduced hESCs, the number of eGFP+ cells decreased
from 84% to 78% eGFP+ cells during 4 weeks of EB
differentiation [12]. During EB differentiation of mESCs, EF1a
was shown as a superior promoter compared to the PGK
promoter [8]. Moreover, during EB differentiation of EF1a-eGFP
transduced mESCs, eGFP expression remained stable as observed
by fluorescence microscopy, although quantitative qPCR analysis
showed that eGFP mRNA levels decreased by approximately 40%
[27].
HIV-1 based lentiviral vectors are known to be more efficiently
expressed than their MLV gammaretrovirus counterparts that are
often transcriptionally silent in both ES cells and in transgenic
animals [26,28]. Silencing have mainly been studied for retroviral
vectors and encompasses several related phenomena including
complete transcriptional silencing, which is observed shortly after
infection, and variegation. The latter refers to the situation when
genetically identical sister cells that inherit the same provirus either
express or silence the provirus [29–31]. Finally, extinction refers to
the progressive silencing of an initially expressed provirus during
long-term culture or EB differentiation of mESCs [23,30]. Little is
known about silencing of SIN lentiviral vectors in ES cells but it
has been shown that transgenes are efficiently expressed at
multiple copy integrations but single copy integrations results in
inconsistent expression [12,13,23,28]. Detailed examination of
mESC clones with single copy SIN lentivirus integrations suggests
that lentiviral vectors are silenced by similar epigenetic modifica-
tions as their retroviral counterparts [32]. However, since we
observed promoter-specific differences in the degree of eGFP
inactivation, we conclude that the stability of lentiviral-mediated
transgene expression in differentiating hESCs is at least partly
dependent on the applied promoter.
Gene expression analysis of eGFP+ and eGFP2 separated cells
revealed that marker genes characteristic for the three germ layers
were expressed in equal levels in EF1a-eGFP+ and eGFP2cells
(Fig. 4). Thus, we conclude that activity of the EF1a promoter
does not show any preference to endodermal, mesodermal or
ectodermal hESC derivatives. The EF1a, PGK and UbC
promoters were active in cells differentiating towards ectodermal
lineages and in SOX17+ early endoderm. Notably, the EF1a
promoter remained active during later stages of differentiation,
here marked as ALBUMIN+ late endoderm/hepatoblast cells and
in PPARc+ and CD31+ late mesoderm while the ACTB promoter
was not active in these populations.
In summary, the ACTB, EF1a and PGK promoters were the
most stable promoters in terms of maintaining transgene (eGFP)
expression during long term culture of undifferentiated hESCs.
Furthermore, the intensity of eGFP expression from the ACTB
and PGK promoter were expressed at stable levels during long
term culture, whereas the intensities of eGFP expression from
the other promoters decreased to various extents. In addition,
our data demonstrate that during hESC differentiation, expres-
sion of constitutive promoters may be restricted to specific cell
lineages and careful selection of promoters is thus important to
ensure high transgene expression in differentiated hESC
progenies. Our data provides a guideline to choose a suitable
promoter to obtain stable gene expression in undifferentiated
hESCs and when in vitro differentiation to certain germ layers is
desired.
Materials and Methods
Culture of human embryonic stem cells
The hESC lines SA121 (Cellartis AB), previously adapted to
enzymatic dissociation, and Hues-4 (D.A Melton, Howard Hughes
Medical Institute, Harvard Institute, Cambridge, MA) were
cultured according to protocols at http://www.mcb.harvard.
edu/melton/HUES/ as previously described on mitotically
inactivated mouse embryonic feeder cells (Lund Transgenic Core
Facility, Lund University, Sweden) [19,20].
eGFP+ cells were transferred to feeder free culture conditions
using Matrigel Matrix (BD Biosciences) in mTESR.1 cell culture
medium (Stemcell Technologies) according to manufacturer’s
instructions, and passaged every fifth to sixth day at 1:3 split ratio.
For spontaneous differentiation of embryoid bodies, cells were
dissociated with 0,05% tryspin-EDTA (Gibco) and cultured as
suspension cultures in Knockout-DMEM (Gibco) supplemented
with 20% Knockout-serum replacement (Gibco), 1% Non-
essential amino acids (Gibco), 1% Glutamax (Gibco), 0.1% beta-
mercaptoethanol (Gibco), 1% penicillin-streptomycin (Invitrogen)
for 22 days with medium change every third day.
Cells were karyotyped by standard G-banding at Divison of
Clinical Genetics, Linkoping University and Lund University,
Sweden. SA121 were found to be karyotypically normal and Hues-
4 was normal in 60% of the analyzed cells.
DNA constructs and recombinant lentiviral production
The backbone of the lentiviral construct, pTRIP, has been
previously described [33]. The vector, pTRIP DU3.CMV-eGFP
and pTRIP DU3.PGK-eGFP expresses the eGFP gene under the
control of an internal cytomegalovirus (CMV) promoter and
mouse phophoglycerate kinase promoter respectively kindly
provided Alexis Pierre Bemelmans [34]. New lentiviral vectors
pTRIP DU3.ACTB-eGFP, pTRIPDU3.EF1a-eGFP and pTRIP-
DU3.UbC-eGFP were constructed using the Gateway in vitro
recombination system (Invitrogen). Briefly the RIP405 promoter
was removed by MluI and BamHI restriction from pTRIP
DU3.RIP405-eGFP [35]. Both extremities were filled by klenow
polymerase and the RFA Gateway cassette was cloned to generate
the pTRIP DU3.RFA (Gateway)-eGFP destination vector. All
promoters were cloned by PCR into Gateway compatible Entry
clones and finally inserted into the destination lentiviral vector by
LR Clonase II recombination according to manufacturer’s
recommendations (Invitrogen). The elongation factor-1a (EF1a)
promoter was amplified from vector pLOX/EWgfp (kindly
provided by Dr. S. Karlsson Dept of Molecular Medicine and
Gene Therapy, Lund University, Sweden) with primers forward 59
GGGGACAAGTTTGTACAAAAAAGCAGGCT93 and reverse
59GGGGACCACTTTGTACAAGAAAGCTGGGTACTTTG-
AACCACTGTCTGAGGCTT 93. The resulting PCR product
was recombined into pDONR201 (Invitrogen) to generate EF1a
entry clone. The human beta actin promoter (ACTB) was amplified
from ACTB plasmid (kindly provided by Dr. E.G Stanley, Monash
Immunology and Stem Cell Laboratories, Monash University,
Australia) with primers: forward 59 CACCCTTTCTAGAACTA-
GACT 39 and reverse 59 GTTAACCTCGACGTGAGCTGC 39
and the resulting PCR product was cloned into pENTR/D-Topo
vector. Human ubiquitinC (UbC) promoter was amplified from
human genomic DNA using the following primers: forward 59
GCCTCCGCGCCGGGTTTTGGC 39 and reverse 59 TCCA-
CAACAAGAACCGCGAC 39 and cloned into the pENTR/D
Topo vector (Invitrogen).
Lentiviral vector stocks were produced by transient transfection
of 293T cells with the p8.91 encapsidation plasmid [36], the VSV
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PLoS ONE | www.plosone.org 8 August 2010 | Volume 5 | Issue 8 | e12413glycoprotein-G-encoding pHCMV-G plasmid [37], and the
lentiviral recombinant vector as previously described [38].
Supernatants were treated with DNAseI (Roche Diagnostic) prior
to ultracentrifugation and the resulting pellet was resuspended in
Phosphate Buffered Saline, separated into aliquots and frozen at
280uC until use. The transduction efficiency of each vector stock
was determined by FACS analysis as previously described [35].
Lentiviral transduction
hESCs were transduced with vector particles harboring ACTB-,
CMV-, EF1a-, PGK- and UbC-EGFP, respectively, at MOI 1
previously determined to generate low number of integrated viral
vector copies. Briefly, 500000 hESCs were dissociated to single
cells dissolved in 200 ml cell culture medium, incubated with virus
at MOI 1 under gentle shaking for 1 h at 37uC, thereafter seeded
on MEF cells in 2 ml cell culture medium as described above.
Medium was changed the next day and cells were cultured to
confluence. eGFP expressing cells were isolated using FACS
sorting and cultured on Matrigel matrix (BD biosciences) in
mTESR.1 medium (Stemcell Technologies). hESC line SA121
was transduced in three separate experiments and at different
passages for eGFP expression in undifferentiated cells and EB
differentiated cells.
Flow cytometry
To isolate eGFPexpressing cells, trypsin dissociated cells were
filtered through Filcon filter 50M (BD bioscieneces) to remove
aggregated cell clumps and were sorted on FACSVantageSE
DiVAOption (BD Biosciences) equipped with DiVa 5.0.3 software.
Analysis was performed in FlowJo (Tree Star). Cells were collected
in cell culture medium. Reanalysis of sorted cells reproducibly
showed a high purity (.98%).
To analyze eGFP expression, transduced cells were dissociated
to single cells and measured on a FACSCalibur equipped with
CellQUEST software (BD biosciences). A population of 5000 cells
was analyzed and 7-aminoactinomycin-D (7AAD) (Sigma) were
used to exclude dead cells.
Real time quantitative PCR
For quantification of copy number of integrated viral vectors,
genomic DNA (gDNA) was extracted (Sigma GenElute Genomic
Mammalian DNA Mini prep kit) from eGFP+ FACS sorted cells
cultured without MEF cells. Quantification of eGFP was compared
to a single copy reference gene CDX2 using PCR cycling conditions
50uC for 2 min, 95uC for 2 min followed by 40 cycles, denaturation
at 95uC for 15 sec, annealing at 60uC for 25 sec, and extension at
73uC for 30 sec. The correct PCR-products were confirmed by
agarose gel electrophoresis (2% w/v) and melting curve analysis.
CDX2 was amplified with forward (fwd) 59AGAGGGACT-
CAAGGGAAAGG93 and reverse (rev) 59 GGTCTGGGAAGG-
GAAGAGAA93 primers and eGFP with fwd primer 59 CTTGTA-
CAGCTCGTCCATGCCG93 and rev primer 59AACATCG-
AGGACGGCAGCGT93.
Briefly, eGFP and CDX2 were amplified from plasmid and
genomic DNA, respectively, followed by purification of PCR
products. Serial dilution of eGFP and CDX2 PCR products, mixed
in 1:1 molar ratio, were used for generation of standard curve by
qPCR. Linear amplification of eGFP and CDX2 verified that the
2
2DDCT method could be used to compare quantified PCR
product of eGFP cDNA to the reference gene CDX2 [39].
mRNA gene expression analysis including mRNA extraction,
cDNA synthesis and qPCR amplification were performed on
eGFP+ EB isolated by FACS sorting, as described in [40]. The
following primers were used for amplification; SOX17 fwd
59AAGGGCGAGTCCCGTATC93 and rev 59TTGTAGTT-
GGGGTGGTCCTG93, ALBUMIN fwd 59GCAAGGCTGAC-
GATAAGGAG93 and rev 59 TGGCTTTACACCAACGAA-
AA93, PPARc fwd 59GCTGGCCTCCTTGATGAATA93 rev
59TTGGGCTCCATAAAGTCACC93, CD31 fwd 59 CCTGT-
CTTTCAGCCTTCAGC93 and rev 59CGCCTGTGAAATAC-
CAACCT 93, PAX6 fwd 59GAACAGACACAGCCCTCACA93
and rev 59ATCATAACTCCGCCCATTCA93 and NESTIN fwd
59 AGCGTTGGAACAGAGGTTG93 and rev 59GCTGAGG-
GAAGTCTTGGAG93.Ct values were normalized to GAPDH
amplified with fwd 59 GTTCGACAGTCAGCCGCATC93 and
rev 59GGAATTTGCCATGGGTGGA93 and plotted as relative
mRNA expression. qPCR measurements were performed on three
biological replicates, PCR-amplified as three technical replicates
and plotted as standard deviation of the mean (6 s.d.).
Immunocytochemistry
Cells were washed once in PBS and fixed in 4% PFA for
15 min, washed three times in PBS, permeabilized in 0,25
TritonX-100 for 15 min and blocked in 5% skim milk (Sigma)
in 0,1% Triton X-100 (block buffer) (BDH). Primary antibodies
mouse-a-Oct 3/4 (1:500) (SantaCruz), mouse-a-Nanog (1:500)
(Sigma) and mouse-a-hES-Cellect (1:500) (Cellartis AB) were
incubated in block buffer 4uC over night. As secondary antibody,
Cy3 donkey-a-mouse (Jackson ImmunoResearch) was added in a
1:1000 dilution in PBS for 2 h at room temperature. Cell nuclei
were stained with DAPI (Sigma). Immunostained eGFP expressing
cells were visualized with Nikon Eclipse TE 2000-U Axioplan 2
fluorescence microscope and AxioVision LE software (Zeiss).
Supporting Information
Figure S1 Transduction efficiency in hESCs and determination
of number of integrated eGFP copies. A. Initial titration of the
viral vector particles (MOI) needed to transduce hESC line SA121
at low transduction efficiency, measured as eGFP+ cells by FACS
analysis. B–E. Transduction of hESC line Hues-4 with pTRIP-
ACTB-, CMV-, EF1a-, PGK-or UbC-eGFP lentiviral vectors. B.
Transduction efficiency measured by FACS analysis. C. eGFP
copy numbers were measured by qPCR of eGFP+ cell
populations. (D) 10 days after transduction, eGFP+ and eGFP–
cells were isolated by FACS sorting, referred to as day 0. Sorted
eGFP+ cells were maintained as undifferentiated cells for 50 days
and promoter activities were monitored by FACS analysis at day
0, 15, 30, and 50. E. Intensity of eGFP fluorescent signal detected
by FACS analysis (*p#0.04 students t’test). B–E. Data are shown
as mean of three independent experiments. Error bars represent
standard deviation of the mean (6 s.d.). F. Standard curve for
amplification by qPCR of eGFP and the reference gene CDX2 used
to determine the number of integrated eGFP copies in transduced
hESCs. Results are shown as five technical replicates of each
dilution of DNA.
Found at: doi:10.1371/journal.pone.0012413.s001 (0.58 MB TIF)
Table S1 % eGFP+ cells of hESC line Hues-4 transduced with
pTRIP-ACTB-, CMV-, EF1a-, PGK or UbC-eGFP lentiviral
vectors. Data are shown as mean of three independent
experiments 6 s.d.
Found at: doi:10.1371/journal.pone.0012413.s002 (0.03 MB
DOC)
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